Flamma USA, based in Malvern, PA, is a trusted small molecule CDMO specializing in early-stage development and cGMP manufacturing of APIs, NCEs, RSMs, and advanced intermediates. The site is purpose-built to support drug development programs from preclinical to Ph. 3 and onward to commercial supply, offering integrated capabilities in process development, analytical development, and GMP manufacturing.